PI Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
PIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
PI Industries reported FY2026 revenue of Rs 61,827 million, down 18.3% from Rs 75,712 million in FY2025. Full-year PAT fell 23.1% to Rs 14,348 million from Rs 18,665 million, with basic EPS at Rs 94.57 vs Rs 123.03 prior year. Q4 standalone PAT was Rs 1,978 million on revenue of Rs 13,914 million. The company recognized an exceptional item of Rs 1,100 million as an impairment provision on its investment in PI Health Sciences Ltd. Auditors issued an unmodified (clean) opinion with no qualifications. The Board recommended a final dividend of Rs 10 per share, making total dividend for FY26 Rs 15 per share (including Rs 5 interim). Key management changes include the resignation of Joint MD Rajnish Sarna and appointment of Dr. Atul Kumar Gupta as Whole-time Director.
Revenue and profit both declined significantly year-over-year, signaling earnings pressure. Despite clean audit findings and maintained dividend, the sharp drop in PAT and operating cash flow may weigh on investor sentiment near-term.